Wnt/β-catenin signaling in the development and therapeutic resistance of non-small cell lung cancer

Zixu Zhang,David Westover,Zhantong Tang,Yue Liu,Jinghan Sun,Yunxi Sun,Runqing Zhang,Xingyue Wang,Shihui Zhou,Nigaerayi Hesilaiti,Qi Xia and Zhenfang Du

DOI: https://doi.org/10.1186/s12967-024-05380-8

IF: 8.44

2024-06-13

Journal of Translational Medicine

Abstract:Wnt/β-catenin signaling is a critical pathway that influences development and therapeutic response of non-small cell lung cancer (NSCLC). In recent years, many Wnt regulators, including proteins, miRNAs, lncRNAs, and circRNAs, have been found to promote or inhibit signaling by acting on Wnt proteins, receptors, signal transducers and transcriptional effectors. The identification of these regulators and their underlying molecular mechanisms provides important implications for how to target this pathway therapeutically. In this review, we summarize recent studies of Wnt regulators in the development and therapeutic response of NSCLC.

medicine, research & experimental

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly focus on the role of the Wnt/β - catenin signaling pathway in the development and treatment resistance of non - small - cell lung cancer (NSCLC). Specifically, the paper explores the following aspects:

1. **Regulatory mechanism of the Wnt/β - catenin signaling pathway**: The paper describes in detail the key components of the Wnt/β - catenin signaling pathway and their interactions, including Wnt ligands, receptors, signal transduction factors, and transcriptional effectors. How these components transmit signals within cells and their functions under normal physiological and pathological conditions.

2. **Role of Wnt regulators**: The paper summarizes a variety of Wnt regulators discovered in recent years, including proteins, miRNAs, lncRNAs, and circRNAs, and how these regulators promote or inhibit the development and treatment response of NSCLC by affecting the Wnt/β - catenin signaling pathway.

3. **Relationship between the Wnt/β - catenin signaling pathway and NSCLC**: The paper discusses the abnormal expression and functional changes of the Wnt/β - catenin signaling pathway in NSCLC, especially how these changes lead to the occurrence, development, and treatment resistance of NSCLC.

4. **Potential treatment strategies**: Based on the understanding of the Wnt/β - catenin signaling pathway and its regulators, the paper proposes possible treatment strategies, including drugs and methods targeting the Wnt/β - catenin signaling pathway, to improve the prognosis of NSCLC patients.

In summary, the main purpose of this paper is to provide a theoretical basis and experimental evidence for the development of new treatment strategies by summarizing and analyzing the role of the Wnt/β - catenin signaling pathway in NSCLC.